CANCER SUPPRESSING & DEVELOPMENTAL FUNCTIONS OF RB GENE

在这项拨款中提出的研究的目的是获得洞察力 隐性癌基因在癌症中的作用。 已有几种方法被应用于鉴定遗传因素 参与了特尔莫斯的发生。癌基因最初定义于 肿瘤诱导逆转录病毒和肿瘤DNA中能够 在培养中转化非肿瘤细胞。大多数癌基因是 存在于正常细胞中的原癌基因的激活版本。 另一类癌症基因已被提出，其缺失 基因功能与肿瘤的发生有关。参与其中的 这类基因已被认为适用于许多肿瘤类型，例如 视网膜母细胞瘤，乳腺癌，结肠癌，肾细胞癌， 由于肿瘤的形成与基因的丢失有关 功能而不是激活，后一类基因已经被 称为“隐性癌基因”或“抑癌基因”。 视网膜母细胞瘤易感性(Rb)基因是唯一的人类 到目前为止克隆的隐性癌基因。Rb基因定位于 染色体带13q14。我们和其他人发现了突变 Rb基因失活不仅在视网膜母细胞瘤中，而且在 在相当大比例的骨肉瘤和软组织中 肉瘤。染色体上存在肿瘤抑制基因 13对于一些乳腺癌来说，已经被建议。研究项目： 果蝇还表明，24个基因座与组织- 特定的肿瘤。两个等位基因的失活 致死性(2)巨型幼虫(L(2)gl)基因导致恶性神经母细胞瘤 在幼虫脑和成像盘的肿瘤中。此外， L(2)gl基因的发育调控表达 正常生长。 本研究主要针对Rb基因的两个方面进行了研究：(1)Rb基因 参与乳腺癌的发生和(2)发育 以果蝇为模型研究Rb基因的作用。 一、Rb基因在乳腺癌中的作用我们已经检测到 9个乳腺肿瘤细胞中2/4的Rb基因突变 台词。原发乳腺肿瘤将研究Rb基因 失活。通过逆转录病毒介导的基因转移，我们将 将正常Rb基因导入缺失Rb的乳腺癌细胞系 在体内和体外测试其抑瘤活性的功能 体外转化表型的可逆性。此外, 转化生长因子受体和受体的调控 将探索Rb基因对表皮生长因子的影响。II. Rb基因在Drosphila中的同源性。我们将使用Drosphila系统作为 研究Rb的发育、表达和功能的模型。 我们的初步数据表明，在这一点上存在Rb同源基因 有机体。Drosphila Rb基因(DRB)的基因组和cDNA克隆 将被刻画成Exesnivley的。此外，DRB还将 定位于多线染色体。经典遗传程序 将用于鉴定可能的DRB突变体。然后我们将使用 P-元件介导的生殖系转化研究DRB基因 在它的正常环境中。

The aim of the research proposed in this grant is to gain insight into the action of recessive oncogenes in cancer. Several approaches have been applied to identify genetic elements involved in turmorigenesis. Oncogenes were initially defined in tumor-inducing retroviruses and in tumor DNA capable of transforming nonneoplastic cells in culture. Most onocogenes are activated versions of proto-oncogenes that exist in normal cells. Another class of cancer genes has been proposed for which loss of gene function is associated with oncogenesis. The involvement of such genes has been suggested for many tumor types, e.g. retinoblastoma, breast cancer, colon cancer, renal cell carcinoma, etc. Since tumor formation is associated with loss of gene function instead of activation, the latter class of genes have been termed "recessive oncogenes" or cancer suppressor genes". The retinoblastoma susceptibility (RB) gene is the only human recessive onocogene cloned to date. RB gene is localized in chromosome band 13q14. We and other have found mutational inactivation of the RB gene not only in retinoblastomas but also in a significant percentage of osteosarcomas and soft tissue sarcomas. The presence of a tumor suppressor gene on chromosome 13 for some breast caners has been suggested. Studies in Drosophila also suggest the association of 24 loci with tissue- specific tumors. Inactivation of both alleles of the lethal(2)giant larvae (l(2)gl) gene causes malignant neuroblastoma in the larval brain and tumors of the imaginal discs. Moreover, developmentally regulated expression of l(2)gl is important for normal growth. This proposal focuses on two aspects of RB function: (1) RB gene involvement in the genesis of breast cancer and (2) a developmental role for the RB gene using the fruit fly Drosophila as a model. I. Function of the RB gene in breast cancer. We have detected mutation of the RB gene in two outy of nine breast tumor cell lines. Priminary breast tumors will be stuied for RB gene inactivation. By retrovirus mediated gene transfer we will introduce normal RB gene into breast tumor cell lines lacking RB function to test for its tumor suppression activity invivo and reversibility of transformed phenotype in vitro. In addition, modulation of receptors for transforming growth factor and epidermal growth factor by the RB gene will be explored. II. The RB gene homolog in Drosphila. We will use the Drosphila system as a model to study the development expression and function of RB. Our preliminary data suggests the presence of a RB homolog in this organism. Genomic and cDNA clones of the Drosphila RB gene (dRB) will be extesnivley characterized. In addition, dRB wil be localized to polytene chromosomes. Classical gentic procedures will be used to identify putative dRB mutants. We will then use P-element mediated germ line transformation to study the dRB gene in its normal environment.